文献速递甲状腺疾病

成人FDG-PET/CT甲状腺偶发瘤的回顾性分析:发病率、治疗与结局

Retrospective Analyses of 18FDG-PET/CT Thyroid Incidentaloma in Adults: Incidence, Treatment, and Outcome in a Tertiary Cancer Referral Center.
PubMed 文献 · Thyroid · 2021-09-03

本研究回顾性分析三级癌症转诊中心1003例因非甲状腺恶性肿瘤行18FDG-PET/CT发现的甲状腺偶发瘤(TI),TI发生率为1.9%(1003/52,693)。47例(6%)行甲状腺手术,31例(66%)病理为甲状腺恶性,占全部患者的4%;中位随访6年,仅1例死于甲状腺髓样癌。多数TI可采取不干预或超声随访策略。

要点

  • FDG阳性TI在肿瘤患者PET/CT中发生率为1.9%。
  • 仅6%的TI患者接受甲状腺手术,其中66%为甲状腺恶性。
  • 中位随访6年,仅1例死于甲状腺癌,支持多数TI可保守管理。

核心结论

  • 本中心TI发生率与现有文献相当。
  • 不足半数患者进一步行甲状腺检查,仅少数接受手术。
  • 仅1例死于甲状腺癌,对多数TI不干预策略似乎合理。
  • 对原发非甲状腺恶性肿瘤治愈或稳定的亚组,积极甲状腺治疗可能获益。
  • 等待观察联合超声随访可作为替代策略,应纳入共享决策。

研究设计与样本

  • 回顾性队列研究,纳入2010年1月至2020年1月因非甲状腺恶性肿瘤行18FDG-PET/CT发现TI的1003例患者。
  • 采用Kaplan-Meier法对在本队列中患病率≥5%的潜在恶性肿瘤患者进行生存分析。
  • 采用Logistic回归和Cox回归分析甲状腺恶性及死亡的预测因素。
  • 采用倾向评分加权法控制干预组(追加TI诊断)与对照组(未追加TI诊断)的基线差异。

主要发现

  • FDG阳性TI占本中心肿瘤患者18FDG-PET/CT扫描的1.9%(1003/52,693)。
  • 47例(6%)行甲状腺手术,其中31例(66%)检出甲状腺恶性,占全部患者的4%。
  • 中位随访6年,观察334例死亡(42%),其中38%死于不同类型癌症,4%死于其他原因。
  • 1例患者死于甲状腺髓样癌。
  • 多变量分析中,调整年龄、性别及非甲状腺恶性肿瘤类型和分期后,[原文此处缺失具体预测变量名称]为生存的独立预测因素(P < .05)。

临床怎么用

  • 对多数FDG-PET/CT发现的TI,可考虑不立即行甲状腺诊断和治疗。
  • 等待观察联合超声随访可作为替代管理策略。
  • 对原发非甲状腺恶性肿瘤已成功治疗或推测稳定的患者,积极甲状腺治疗可能获益。
  • TI管理决策应纳入与癌症患者的共享决策。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: A thyroid incidentaloma (TI) is an unexpected, asymptomatic thyroid lesion discovered during the investigation of an unrelated condition. The aim of the present study is to examine the incidence of 18Fluorodeoxyglucose (FDG)-positron emission tomography (PET) TI, the associated management strategies and the outcomes in a tertiary cancer referral center. Methods: This study involves a retrospective cohort study of 1003 patients with TI found on 18FDG-PET/CT scans performed between January 2010 and January 2020 for a nonthyroidal malignancy. The Kaplan-Meier method was used for survival analyses in patients concerning an underlying malignancy, with a prevalence of 5% or higher in this cohort. Logistic- and cox regression analyses were performed to analyze predictors of thyroid malignancy and mortality. A propensity score weighted method was used to control for baseline differences between the intervention (additional TI diagnostics) and control (no TI diagnostics) group. Results: FDG-positive TI occurred in 1.9% (1003/52,693) of the oncologic 18FDG-PET/CT scans performed in our center. Thyroid surgery was performed in 47 patients (6%) and a thyroid malignancy was detected in 31 of them, which is 66% of those who had an operation and 4% of all patients. During the follow-up (median 6 years), 334 deaths (42%) related to different types of cancer (38%) or other causes (4%) were observed. One patient died from medullary thyroid cancer. In multivariate analysis adjusted for age, gender and the type- and stage of nonthyroidal malignancy, were independent predictors of survival (P < .05). Conclusions: The incidence of TI in this tertiary cancer referral center was comparable to current literature. Further thyroid workup was performed in less than half of the patients, and only a minority of patients underwent thyroid surgery. Since only one patient died from thyroid cancer, the strategy to withhold from thyroid diagnostics and treatment seems valid for most TI. Active thyroid treatment might benefit a subgroup of patients in whom the primary nonthyroidal malignancy is successfully treated or presumably stable. A wait-and-see policy with ultrasound follow-up could be an alternative strategy. These considerations should be part of the shared decision making in cancer patients with a TI.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Piek MW, de Boer JP, Vriens MR, et al. Retrospective Analyses of 18FDG-PET/CT Thyroid Incidentaloma in Adults: Incidence, Treatment, and Outcome in a Tertiary Cancer Referral Center. Thyroid. 2021. PMID: 34340567. doi:10.1089/thy.2021.0226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。